Trexquant Investment LP Solid Biosciences Inc. Transaction History

Trexquant Investment LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$4.33 - $11.64 $104,240 - $280,221	-24,074 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$4.6 - $10.13 $45,756 - $100,763	9,947 Added 70.41%	24,074 $138,000
Q1 2019 May 13, 2019	BUY	$7.19 - $32.37 $101,573 - $457,290	14,127 New	14,127 $130,000
Q4 2018 Feb 13, 2019	SELL	$21.32 - $46.34 $154,250 - $335,269	-7,235 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$36.35 - $51.7 $262,992 - $374,049	7,235 New	7,235 $341,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $36.5M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.